export const hypertrophicCardiomyopathyIcdManagement = {
  title: "ICD Management and Therapeutic Procedures",
  sections: [
    {
      title: "Indications for ICD implantation - General principles",
      evidenceLevel: "B",
      guidelines: [
        {
          organization: "ACC/AHA/AMSSM/SCMR 2024",
          recommendation: "Apply individual clinical judgment when assessing the prognostic strength of conventional risk markers within the clinical profile of the individual patient, and a thorough and balanced discussion of the evidence, benefits, and estimated risks to engage the fully informed patient's active participation in decision-making of placing an ICD."
        },
        {
          organization: "ESC 2022",
          recommendation: "Consider performing ICD implantation in ≥ 16 years old patients with HCM with an estimated 5-year risk of sudden death of ≥ 6%.",
          evidenceLevel: "C"
        }
      ]
    },
    {
      title: "Indications for ICD implantation - Post cardiac arrest",
      evidenceLevel: "B",
      guidelines: [
        {
          organization: "ACC/AHA/AMSSM/SCMR 2024",
          recommendation: "Perform ICD implantation in patients with HCM and a previous documented cardiac arrest or sustained VT."
        },
        {
          organization: "ESC 2023",
          recommendation: "Perform ICD implantation in patients with a history of survived cardiac arrest due to VT or VF or spontaneous sustained VT with hemodynamic compromise."
        },
        {
          organization: "ESC 2022",
          recommendations: [
            "Perform ICD implantation in patients with HCM with hemodynamically not-tolerated VT or VF.",
            "Consider performing ICD implantation in patients with HCM presenting with hemodynamically tolerated sustained monomorphic VT."
          ],
          evidenceLevels: ["B", "C"]
        }
      ]
    },
    {
      title: "Indications for ICD implantation - Pediatric patients",
      evidenceLevel: "C",
      guidelines: [
        {
          organization: "ACC/AHA/AMSSM/SCMR 2024",
          recommendations: [
            "Consider performing ICD implantation in pediatric patients with HCM having ≥ 1 conventional risk factors, including unexplained syncope, massive LVH, nonsustained VT, or family history of early HCM-related SCD, after considering the relatively high complication rates of long-term ICD implantation in younger patients.",
            "Consider taking into account additional factors, such as extensive late gadolinium enhancement on contrast-enhanced cardiac MRI and systolic dysfunction, in risk stratification for ICD shared decision-making in pediatric patients with HCM."
          ]
        },
        {
          organization: "ESC 2022",
          recommendation: "Consider performing ICD implantation in < 16 years old pediatric patients with HCM with an estimated 5-year risk of sudden death of ≥ 6% (based on HCM Risk-Kids score)."
        }
      ]
    },
    {
      title: "Technical considerations for ICD implantation",
      evidenceLevel: "B",
      guidelines: [
        {
          organization: "ACC/AHA/AMSSM/SCMR 2024",
          recommendations: [
            "Use either a single-chamber transvenous ICD or a subcutaneous ICD in patients with HCM receiving an ICD after a shared decision-making discussion, taking into account patient preferences, age, lifestyle, and potential need for pacing for bradycardia or VT termination.",
            "Use single-coil ICD leads in preference to dual-coil leads if defibrillation threshold is deemed adequate in patients with HCM receiving a transvenous ICD.",
            "Consider using a dual-chamber ICD in patients with HCM receiving an ICD with a need for atrial or atrioventricular sequential pacing for bradycardia/conduction abnormalities, or as an attempt to relieve symptoms of obstructive HCM (most commonly in patients aged > 65 years).",
            "Program antitachycardia pacing to minimize the risk of shocks in patients with HCM and pacing-capable ICD."
          ],
          evidenceLevels: ["B", "B", "C", "B"]
        },
        {
          organization: "ESC 2023",
          recommendations: [
            "Counsel patients before ICD implantation on the risk of inappropriate shocks, implant complications, and the social, occupational, and driving implications of the device.",
            "Consider placing subcutaneous defibrillators as an alternative to transvenous defibrillators in patients with an indication for an ICD when pacing therapy for bradycardia, cardiac resynchronization, or anti-tachycardia pacing is not anticipated."
          ],
          evidenceLevels: ["B", "C"]
        }
      ]
    },
    {
      title: "Catheter ablation - Ventricular arrhythmia",
      evidenceLevel: "C",
      guidelines: [
        {
          organization: "ACC/AHA/AMSSM/SCMR 2024",
          recommendation: "Consider performing catheter ablation to reduce arrhythmia burden in patients with HCM and recurrent symptomatic sustained monomorphic VT, or recurrent ICD shocks despite optimal device programming, and if antiarrhythmic drug therapy is either ineffective, not tolerated, or not preferred."
        },
        {
          organization: "ESC 2022",
          recommendation: "Consider performing catheter ablation in selected patients with HCM and recurrent, symptomatic sustained monomorphic VT or ICD shocks for sustained monomorphic VT, if antiarrhythmic drugs are ineffective, contraindicated, or not tolerated."
        }
      ]
    },
    {
      title: "Catheter ablation - Atrial fibrillation",
      guidelines: [
        {
          organization: "ACC/AHA/AMSSM/SCMR 2024",
          recommendations: [
            "Consider performing catheter ablation as part of rhythm control strategy in patients with HCM and symptomatic AF if pharmacological therapy is ineffective, contraindicated, or not the patient's preference.",
            "Consider performing concomitant surgical AF ablation for rhythm control in patients with HCM and AF requiring surgical myectomy."
          ],
          evidenceLevel: "C"
        },
        {
          organization: "ESC 2023",
          recommendations: [
            "Perform catheter ablation for rhythm control after one failed or intolerant class I or III antiarrhythmic drug to improve symptoms of recurrences in patients with paroxysmal or persistent AF and cardiomyopathy.",
            "Perform catheter ablation to reverse LV dysfunction in patients with AF when tachycardia-induced component is highly probable, independent of their symptom status.",
            "Consider performing catheter ablation as first-line rhythm control therapy as an alternative to class I or III antiarrhythmic drugs, considering patient choice, benefit, and risk, to improve symptoms in selected patients with paroxysmal or persistent AF without major risk factors for recurrences."
          ],
          evidenceLevels: ["B", "B", "C"]
        }
      ]
    },
    {
      title: "Permanent pacing",
      evidenceLevel: "C",
      guidelines: [
        {
          organization: "ACC/AHA/AMSSM/SCMR 2024",
          recommendations: [
            "Consider offering CRT to improve symptoms in patients with HCM and LVEF < 50%, having NYHA class II-IV HF despite guideline-directed medical therapy, and LBBB.",
            "Consider offering CRT to improve symptoms in selected adult patients with nonobstructive HCM receiving an ICD and having NYHA class II-IV HF, LBBB, and LVEF < 50%."
          ]
        },
        {
          organization: "ESC 2023",
          recommendations: [
            "Consider performing sequential atrioventricular pacing with optimal atrioventricular interval to reduce the LVOT gradient or to facilitate medical treatment with β-blockers and/or verapamil in selected patients with resting or provoked LVOTO ≥ 50 mmHg, sinus rhythm, and drug-refractory symptoms.",
            "Consider placing a dual-chamber implantable cardioverter defibrillator instead of a single-lead device to reduce the LVOT gradient or to facilitate medical treatment with β-blockers and/or verapamil in patients with resting or provoked LVOTO ≥ 50 mmHg, sinus rhythm, and drug-refractory symptoms if there is an indication for an ICD."
          ]
        }
      ]
    }
  ]
}; 